Nutritional supplement sprinkles with zinc and micronutrients

ISRCTN ISRCTN39244429
DOI https://doi.org/10.1186/ISRCTN39244429
Secondary identifying numbers IIN-270
Submission date
12/02/2010
Registration date
16/03/2010
Last edited
15/03/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Not provided at time of registration

Contact information

Dr Nelly Zavaleta
Scientific

Av. La Molina 1885
La Molina
Lima
Lima 12
Peru

Study information

Study designInterventional single centre phase III double blind randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typePrevention
Participant information sheet Not available in web format, please use contact details below to request a patient information sheet (in Spanish)
Scientific titleEfficacy of the nutritional supplement sprinkles with zinc and micronutrients on anaemia and acute diarrhoea in Peruvian children
Study acronymSUNSZIM
Study hypothesis1. Children 6 to 17 months of age that consume the nutritional supplement sprinkles with zinc and micronutrients for a 6 month period will have a lower prevalence of anaemia than will those children that consume the nutritional supplement sprinkles with iron alone.
2. Children 6 to 17 months of age that consume the nutritional supplement sprinkles with zinc and micronutrients for a 6 month period will have a lower incidence and prevalence of acute diarrhoea than will those children that consume the nutritional supplement sprinkles with iron alone.
3. Children 6 to 17 months of age that consume the nutritional supplement sprinkles with zinc and micronutrients for a 6 month period will have better growth than those children that consume the nutritional supplement sprinkles with iron alone.
4. The adherence of the nutritional supplement sprinkles with zinc and micronutrients and the nutritional supplement sprinkles with iron alone will be similar, in both cases greater than 75% of the offered doses.
Ethics approval(s)1. Instituto de Investigacion Nutricional (IIN) Institutional Review Board (IRB) approved on the 26th of June 2009 (ref: 284-2009/CEI-IIN)
2. Mount Sinai Hospital IRB approved on the 22nd of October 2009
3. Peruvian NIH authorisation received on the 18th of September 2009
ConditionAnaemia and diarrhoea
InterventionResearch product:
Micronutrient supplement as sprinkles, packaged into individual sachets, each sachet intended for once daily use to be mixed with food. The iron portion of the powder is lipid encapsulated to prevent changing the taste, texture, or colour of the food. The composition used in this study is outlined in the table below.

Micronutrient Amount
Iron as fumarate 12.5mg
Zinc as gluconate 10 mg
Folic Acid 160mcg
Vitamin A 300mcg RE
Vitamin C 30mg

Control Product:
The control group is also a powdered sprinkles form having the following composition per sachet.
Micronutrients Quantity
Iron as fumarate 12.5mg
Route of administration (both groups): Oral
Presentation Form: Powder
Duration of supplementation per subject: 6 months.
Intervention typeOther
Primary outcome measure1. Anemia:
Haemoglobin (Hb) is measured by HemoCue® at baseline and 6 months later (end of the study participation). Prevalence of anaemia is the percentage of children with Hb below 11 g/dl (WHO definition). We will also compare mean Hb values at baseline and end of the study.
2. Diarrhoea:
Morbidity is recorded by home surveillance once a week and we register the daily morbidity, prevalence of diarrhoea is registered as the days with morbidity over the number of observation days x 100, incidence as number of episodes of diarrhoea per 100 days of observations.
Secondary outcome measures1. Incidence of severe diarrhoea:
Severe diarrhoea is defined as ≥ 6 liquid or loose stools in the last 24 hr, number of episodes of severe diarrhoea per 100 days of observations.
2. Duration of diarrhoea:
Number of days with diarrhoea ( ≥ 3 liquid or loose stools in the last 24 hr).
3. Adherence to supplementation:
Number of sachets consumed during the study per over the number of sachets given x 100.
4. Changes in weight and length:
Anthropometric measures weight and length will be taken on infants at baseline and monthly through 6 months of intervention, and Z scores determined for weight-for-age (WAZ), length-for-age (LAZ), and weight-for-length (WLZ) compared to WHO references.
5. Serum zinc:
Measured at entry and 6 months post supplementation.
Overall study start date07/01/2010
Overall study end date31/01/2011

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit6 Months
Upper age limit17 Months
SexBoth
Target number of participants902
Participant inclusion criteria1. Aged between 6 months and 17 months, 29 days of age
2. Residents of Villa El Salvador, Lima, Peru
3. Born at term
4. Birth weight equal or higher than 2500g
5. Healthy
6. Parents agree to sign the informed consent form
Participant exclusion criteria1. Age less than 6 months, or equal to/greater than 18 months
2. Not residents in the area of intervention
3. Children with an initial haemoglobin equal to or less than 8g/dL will be evaluated by a doctor to rule out some additional pathology and will receive treatment according to Peruvian Ministry of Health (Ministerio de Salud [MINSA]) norms
4. Weight/Length less than -2 Standard Deviations (SD)
5. Any chronic, congenital, or severe illnesses
6. Children that regularly consume other micronutrient supplements
Recruitment start date07/01/2010
Recruitment end date31/01/2011

Locations

Countries of recruitment

  • Peru

Study participating centre

Av. La Molina 1885
Lima
Lima 12
Peru

Sponsor information

Instituto de Investigación Nutricional (IIN) (Peru)
Research organisation

Av. La Molina 1885
La Molina
Lima
Lima 12
Peru

ROR logo "ROR" https://ror.org/05by4rq81

Funders

Funder type

Charity

United Nations Children's Fund (UNICEF) (USA)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan